SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001079973-23-001784
Filing Date
2023-12-19
Accepted
2023-12-19 06:05:27
Documents
13
Period of Report
2023-12-18
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cdio_8k.htm   iXBRL 8-K 45606
  Complete submission text file 0001079973-23-001784.txt   268246

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cdio-20231218.xsd EX-101.SCH 3860
3 XBRL DEFINITION FILE cdio-20231218_def.xml EX-101.DEF 26726
4 XBRL LABEL FILE cdio-20231218_lab.xml EX-101.LAB 36860
5 XBRL PRESENTATION FILE cdio-20231218_pre.xml EX-101.PRE 25350
7 EXTRACTED XBRL INSTANCE DOCUMENT cdio_8k_htm.xml XML 5492
Mailing Address 311 W. SUPERIOR STREET SUITE 444 CHICAGO IL 60645
Business Address 311 W. SUPERIOR STREET SUITE 444 CHICAGO IL 60645 855-226-9991
Cardio Diagnostics Holdings, Inc. (Filer) CIK: 0001870144 (see all company filings)

IRS No.: 870925574 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41097 | Film No.: 231495546
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)